Clinical Trials Browser

Phase 4 × Neoplasms × Vemurafenib × Clear all

NCT01739764 2021-01-07

An Extension (Rollover) Study of Vemurafenib in Participants With BRAF V600 Mutation-Positive Malignancies Previously Enrolled in an Antecedent Vemurafenib Protocol

Phase 4 Completed

215 enrolled 12 charts

Neoplasms